SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Wallace Rivers who wrote (23291)2/6/2006 4:10:42 PM
From: Paul Senior  Read Replies (2) | Respond to of 78708
 
Following you into JNJ for another small add.

Very low p/e relative to average p/e over the past ten years. Profit margins still wonderfully high, but sales are flat/down (per Yahoo numbers).



To: Wallace Rivers who wrote (23291)2/6/2006 8:07:07 PM
From: E_K_S  Read Replies (2) | Respond to of 78708
 
I bought 1/3 of my position and my next "Buy" target level is $55.00. What do you think if LLY? It's getting close to my 1st "buy" level of $55.

I agree with you on the JnJ Guident purchase. They already have a very effective stint product and those billions of $'s can do a lot of R&D and marketing.

Any other drug companies on your radar list?

EKS


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News